rabbit anti cdk9 antibody Search Results


93
Novus Biologicals mouse anti cdk9
<t>cdk9</t> is necessary for glial survival. ( a–h ) Representative images of 7d old adult brains immunostained with anti-Repo to label glia for Fig. 1i,j. The images are maximum projections of optical sections. The outlined area demarcates the region of the central brain where the number of glia were quantified. ( i ) Number of anti-Repo-expressing glia in the central brain of 7d old adult flies in mir-31a mutants (mir-31a KO/KO) and where UAS-GFP , UAS-CG16947 , UAS-cdk9 RNAi or UAS-p53 RNAi lines were expressed in glia using Repo-Gal4 . Glia were represented as a percentage of the control animals, Repo-Gal4 > UAS-GFP (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). One-way ANOVA was used for statistical analysis and error bars represent SEM. ( j ) Number of anti-Repo-expressing glia in the central brain of 7d old adult flies. UAS-GFP , UAS-CG16947 and UAS-cdk9 RNAi expression was driven by Repo-Gal4 under the control of tubulin Gal80 ts (tubGal80 ts ). Adult-only expression was achieved by rearing the flies at 18 °C then moving the flies to 29 °C to allow Repo-Gal4 activity after eclosion. Data is represented as a percentage of the number of glia in the UAS-GFP control condition (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). One-way ANOVA was used for statistical analysis and error bars represent SEM.
Mouse Anti Cdk9, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti cdk9/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
mouse anti cdk9 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Proteintech rabbit anticdk9
<t>cdk9</t> is necessary for glial survival. ( a–h ) Representative images of 7d old adult brains immunostained with anti-Repo to label glia for Fig. 1i,j. The images are maximum projections of optical sections. The outlined area demarcates the region of the central brain where the number of glia were quantified. ( i ) Number of anti-Repo-expressing glia in the central brain of 7d old adult flies in mir-31a mutants (mir-31a KO/KO) and where UAS-GFP , UAS-CG16947 , UAS-cdk9 RNAi or UAS-p53 RNAi lines were expressed in glia using Repo-Gal4 . Glia were represented as a percentage of the control animals, Repo-Gal4 > UAS-GFP (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). One-way ANOVA was used for statistical analysis and error bars represent SEM. ( j ) Number of anti-Repo-expressing glia in the central brain of 7d old adult flies. UAS-GFP , UAS-CG16947 and UAS-cdk9 RNAi expression was driven by Repo-Gal4 under the control of tubulin Gal80 ts (tubGal80 ts ). Adult-only expression was achieved by rearing the flies at 18 °C then moving the flies to 29 °C to allow Repo-Gal4 activity after eclosion. Data is represented as a percentage of the number of glia in the UAS-GFP control condition (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). One-way ANOVA was used for statistical analysis and error bars represent SEM.
Rabbit Anticdk9, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anticdk9/product/Proteintech
Average 93 stars, based on 1 article reviews
rabbit anticdk9 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc anti cdk9 2316t
3T3-L1 white preadipocytes were infected with a lentiviral vector expressing human HIRA with C-terminal dTAG and HA double tags, followed by lentiviral CRISPR/Cas9- Hira gRNA to delete endogenous Hira . At D4 of adipogenesis, cells were treated with dTAG-13 for 6h. a , Pie charts depicting the genomic distribution of HIRA binding regions at D4. b , Heat maps were aligned around the center of HIRA binding sites on promoters (6,838), primed enhancers (1,998), active enhancers (AEs, 17,862) and other regions (1,751) at D4. c , Average binding profiles of HIRA-HA, H3K27ac, S5P-Pol II, S2P-Pol II, <t>CDK9</t> and SPT6 around the center of HIRA + promoters and AEs. Normalized read counts are shown. d , Profiles of HIRA-HA, H3K27ac, S5P-Pol II, S2P-Pol II, CDK9 and SPT6 on gene bodies of HIRA + promoter-associated genes. g , ChIP–Seq profiles of HIRA-HA, H3K27ac, S5P-Pol II, S2P-Pol II, CDK9 and SPT6 were displayed on Adipoq , Mlxipl (ChREBP) and Fasn loci.
Anti Cdk9 2316t, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cdk9 2316t/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
anti cdk9 2316t - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology anti cdk9
Mutant AIREfsx protein does not interact with P-TEFb. ( A ) Mutant AIREfsx protein does not interact with <t>CDK9.</t> GAL, GAL.AIRE and GAL.AIREfsx chimeras were expressed in HeLa cells. Proteins were immunoprecipitated with anti-GAL antibodies (αGAL) and the co-immunoprecipitation with CDK9 was detected with anti-CDK9 antibodies by western blotting (Top panel, IP:WB). The lower three panels contain 5% of input proteins for immunoprecipitations (WB). ( B ) Mutant AIREfsx protein cannot recruit CDK9 to DNA. Sonicated lysates from HeLa cells co-expressing GAL.AIRE or GAL.AIREfsx fusion proteins and G5HIV2SVEDA were immunoprecipitated with anti-CDK9 (αCDK9) antibodies for ChIP. Enrichment of amplicons is presented as fold enrichment over IgG control (CDK9/IgG). Black and striped bars represent values for the WT GAL.AIRE and mutant GAL.AIREfsx chimeras with SEM depicted by error bars. G5HIV2SVEDA and ChIP amplicons are depicted above and below the bar graph, respectively (promoter, Pr; 5′-end of gene, 5′; 3′-end of gene, 3′, polyadenylation signal, pA; untranscribed region, U). G5HIV2SVEDA contains five GAL binding sites (UAS) and the TATA box (T) upstream of the α-globin gene (αgl) with the inserted fragment from the fibronectin 1 gene (FN1).
Anti Cdk9, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cdk9/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
anti cdk9 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc cdk9
Mutant AIREfsx protein does not interact with P-TEFb. ( A ) Mutant AIREfsx protein does not interact with <t>CDK9.</t> GAL, GAL.AIRE and GAL.AIREfsx chimeras were expressed in HeLa cells. Proteins were immunoprecipitated with anti-GAL antibodies (αGAL) and the co-immunoprecipitation with CDK9 was detected with anti-CDK9 antibodies by western blotting (Top panel, IP:WB). The lower three panels contain 5% of input proteins for immunoprecipitations (WB). ( B ) Mutant AIREfsx protein cannot recruit CDK9 to DNA. Sonicated lysates from HeLa cells co-expressing GAL.AIRE or GAL.AIREfsx fusion proteins and G5HIV2SVEDA were immunoprecipitated with anti-CDK9 (αCDK9) antibodies for ChIP. Enrichment of amplicons is presented as fold enrichment over IgG control (CDK9/IgG). Black and striped bars represent values for the WT GAL.AIRE and mutant GAL.AIREfsx chimeras with SEM depicted by error bars. G5HIV2SVEDA and ChIP amplicons are depicted above and below the bar graph, respectively (promoter, Pr; 5′-end of gene, 5′; 3′-end of gene, 3′, polyadenylation signal, pA; untranscribed region, U). G5HIV2SVEDA contains five GAL binding sites (UAS) and the TATA box (T) upstream of the α-globin gene (αgl) with the inserted fragment from the fibronectin 1 gene (FN1).
Cdk9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk9/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
cdk9 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc pcdk9 cell signaling technology
Mutant AIREfsx protein does not interact with P-TEFb. ( A ) Mutant AIREfsx protein does not interact with <t>CDK9.</t> GAL, GAL.AIRE and GAL.AIREfsx chimeras were expressed in HeLa cells. Proteins were immunoprecipitated with anti-GAL antibodies (αGAL) and the co-immunoprecipitation with CDK9 was detected with anti-CDK9 antibodies by western blotting (Top panel, IP:WB). The lower three panels contain 5% of input proteins for immunoprecipitations (WB). ( B ) Mutant AIREfsx protein cannot recruit CDK9 to DNA. Sonicated lysates from HeLa cells co-expressing GAL.AIRE or GAL.AIREfsx fusion proteins and G5HIV2SVEDA were immunoprecipitated with anti-CDK9 (αCDK9) antibodies for ChIP. Enrichment of amplicons is presented as fold enrichment over IgG control (CDK9/IgG). Black and striped bars represent values for the WT GAL.AIRE and mutant GAL.AIREfsx chimeras with SEM depicted by error bars. G5HIV2SVEDA and ChIP amplicons are depicted above and below the bar graph, respectively (promoter, Pr; 5′-end of gene, 5′; 3′-end of gene, 3′, polyadenylation signal, pA; untranscribed region, U). G5HIV2SVEDA contains five GAL binding sites (UAS) and the TATA box (T) upstream of the α-globin gene (αgl) with the inserted fragment from the fibronectin 1 gene (FN1).
Pcdk9 Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcdk9 cell signaling technology/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
pcdk9 cell signaling technology - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

93
Bethyl a cdk9
Mutant AIREfsx protein does not interact with P-TEFb. ( A ) Mutant AIREfsx protein does not interact with <t>CDK9.</t> GAL, GAL.AIRE and GAL.AIREfsx chimeras were expressed in HeLa cells. Proteins were immunoprecipitated with anti-GAL antibodies (αGAL) and the co-immunoprecipitation with CDK9 was detected with anti-CDK9 antibodies by western blotting (Top panel, IP:WB). The lower three panels contain 5% of input proteins for immunoprecipitations (WB). ( B ) Mutant AIREfsx protein cannot recruit CDK9 to DNA. Sonicated lysates from HeLa cells co-expressing GAL.AIRE or GAL.AIREfsx fusion proteins and G5HIV2SVEDA were immunoprecipitated with anti-CDK9 (αCDK9) antibodies for ChIP. Enrichment of amplicons is presented as fold enrichment over IgG control (CDK9/IgG). Black and striped bars represent values for the WT GAL.AIRE and mutant GAL.AIREfsx chimeras with SEM depicted by error bars. G5HIV2SVEDA and ChIP amplicons are depicted above and below the bar graph, respectively (promoter, Pr; 5′-end of gene, 5′; 3′-end of gene, 3′, polyadenylation signal, pA; untranscribed region, U). G5HIV2SVEDA contains five GAL binding sites (UAS) and the TATA box (T) upstream of the α-globin gene (αgl) with the inserted fragment from the fibronectin 1 gene (FN1).
A Cdk9, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a cdk9/product/Bethyl
Average 93 stars, based on 1 article reviews
a cdk9 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
Biorbyt cdk9
Figure 1| Smad3, Smad4, and cyclin-dependent kinase 9 <t>(CDK9)</t> complex formation in the development and progression of unilateral ureteral obstruction (UUO). (a) Western blotting (WB) demonstrated expression levels of CDK9 in the kidneys 6 h, 12 h, 2 days (d), 4d, and 7d after sham or UUO surgery. (b) Quantitation of relative signal intensities of CDK9/α-tubulin. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group; #Po0.05, versus UUO 12-h group; $Po0.05, versus UUO 24-h group. (c–l) Confocal microscopy demonstrated the expression of CDK9 (green, d, h), α-smooth muscle actin (α-SMA, red, e, i), merged (f, j, k–m) and DAPI (4,6-diamidino-2-phenylindole; blue, c, g) in the mouse kidney with sham operation (c–f) and kidney with UUO (g–m). c–j, × 600. (k) Area in (j), × 1800. Arrows: samples of CDK9+/α-SMA+ myofibroblasts cells. (l) Quantitation of the percentages of CDK9+/α-SMA+ cells in total DAPI(+) cells. (m) Immunoprecipitation (IP)/WB demonstrated the interactions between Smad3 and Smad4, and Smad3 and CDK9 in the kidneys 6 h, 12 h, 2d, 4d, and 7d after sham or UUO surgery. (n) Quantitation of relative signal intensities of Smad4/Smad3 and CDK9/Smad3. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group.
Cdk9, supplied by Biorbyt, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk9/product/Biorbyt
Average 90 stars, based on 1 article reviews
cdk9 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

92
Cell Signaling Technology Inc rabbit anti cdk9
Figure 1| Smad3, Smad4, and cyclin-dependent kinase 9 <t>(CDK9)</t> complex formation in the development and progression of unilateral ureteral obstruction (UUO). (a) Western blotting (WB) demonstrated expression levels of CDK9 in the kidneys 6 h, 12 h, 2 days (d), 4d, and 7d after sham or UUO surgery. (b) Quantitation of relative signal intensities of CDK9/α-tubulin. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group; #Po0.05, versus UUO 12-h group; $Po0.05, versus UUO 24-h group. (c–l) Confocal microscopy demonstrated the expression of CDK9 (green, d, h), α-smooth muscle actin (α-SMA, red, e, i), merged (f, j, k–m) and DAPI (4,6-diamidino-2-phenylindole; blue, c, g) in the mouse kidney with sham operation (c–f) and kidney with UUO (g–m). c–j, × 600. (k) Area in (j), × 1800. Arrows: samples of CDK9+/α-SMA+ myofibroblasts cells. (l) Quantitation of the percentages of CDK9+/α-SMA+ cells in total DAPI(+) cells. (m) Immunoprecipitation (IP)/WB demonstrated the interactions between Smad3 and Smad4, and Smad3 and CDK9 in the kidneys 6 h, 12 h, 2d, 4d, and 7d after sham or UUO surgery. (n) Quantitation of relative signal intensities of Smad4/Smad3 and CDK9/Smad3. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group.
Rabbit Anti Cdk9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti cdk9/product/Cell Signaling Technology Inc
Average 92 stars, based on 1 article reviews
rabbit anti cdk9 - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology anti-cdk9 rabbit polyclonal antibody h169
Figure 1| Smad3, Smad4, and cyclin-dependent kinase 9 <t>(CDK9)</t> complex formation in the development and progression of unilateral ureteral obstruction (UUO). (a) Western blotting (WB) demonstrated expression levels of CDK9 in the kidneys 6 h, 12 h, 2 days (d), 4d, and 7d after sham or UUO surgery. (b) Quantitation of relative signal intensities of CDK9/α-tubulin. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group; #Po0.05, versus UUO 12-h group; $Po0.05, versus UUO 24-h group. (c–l) Confocal microscopy demonstrated the expression of CDK9 (green, d, h), α-smooth muscle actin (α-SMA, red, e, i), merged (f, j, k–m) and DAPI (4,6-diamidino-2-phenylindole; blue, c, g) in the mouse kidney with sham operation (c–f) and kidney with UUO (g–m). c–j, × 600. (k) Area in (j), × 1800. Arrows: samples of CDK9+/α-SMA+ myofibroblasts cells. (l) Quantitation of the percentages of CDK9+/α-SMA+ cells in total DAPI(+) cells. (m) Immunoprecipitation (IP)/WB demonstrated the interactions between Smad3 and Smad4, and Smad3 and CDK9 in the kidneys 6 h, 12 h, 2d, 4d, and 7d after sham or UUO surgery. (n) Quantitation of relative signal intensities of Smad4/Smad3 and CDK9/Smad3. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group.
Anti Cdk9 Rabbit Polyclonal Antibody H169, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cdk9 rabbit polyclonal antibody h169/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
anti-cdk9 rabbit polyclonal antibody h169 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc cdk9 81464
Figure 1| Smad3, Smad4, and cyclin-dependent kinase 9 <t>(CDK9)</t> complex formation in the development and progression of unilateral ureteral obstruction (UUO). (a) Western blotting (WB) demonstrated expression levels of CDK9 in the kidneys 6 h, 12 h, 2 days (d), 4d, and 7d after sham or UUO surgery. (b) Quantitation of relative signal intensities of CDK9/α-tubulin. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group; #Po0.05, versus UUO 12-h group; $Po0.05, versus UUO 24-h group. (c–l) Confocal microscopy demonstrated the expression of CDK9 (green, d, h), α-smooth muscle actin (α-SMA, red, e, i), merged (f, j, k–m) and DAPI (4,6-diamidino-2-phenylindole; blue, c, g) in the mouse kidney with sham operation (c–f) and kidney with UUO (g–m). c–j, × 600. (k) Area in (j), × 1800. Arrows: samples of CDK9+/α-SMA+ myofibroblasts cells. (l) Quantitation of the percentages of CDK9+/α-SMA+ cells in total DAPI(+) cells. (m) Immunoprecipitation (IP)/WB demonstrated the interactions between Smad3 and Smad4, and Smad3 and CDK9 in the kidneys 6 h, 12 h, 2d, 4d, and 7d after sham or UUO surgery. (n) Quantitation of relative signal intensities of Smad4/Smad3 and CDK9/Smad3. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group.
Cdk9 81464, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk9 81464/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
cdk9 81464 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

Image Search Results


cdk9 is necessary for glial survival. ( a–h ) Representative images of 7d old adult brains immunostained with anti-Repo to label glia for Fig. 1i,j. The images are maximum projections of optical sections. The outlined area demarcates the region of the central brain where the number of glia were quantified. ( i ) Number of anti-Repo-expressing glia in the central brain of 7d old adult flies in mir-31a mutants (mir-31a KO/KO) and where UAS-GFP , UAS-CG16947 , UAS-cdk9 RNAi or UAS-p53 RNAi lines were expressed in glia using Repo-Gal4 . Glia were represented as a percentage of the control animals, Repo-Gal4 > UAS-GFP (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). One-way ANOVA was used for statistical analysis and error bars represent SEM. ( j ) Number of anti-Repo-expressing glia in the central brain of 7d old adult flies. UAS-GFP , UAS-CG16947 and UAS-cdk9 RNAi expression was driven by Repo-Gal4 under the control of tubulin Gal80 ts (tubGal80 ts ). Adult-only expression was achieved by rearing the flies at 18 °C then moving the flies to 29 °C to allow Repo-Gal4 activity after eclosion. Data is represented as a percentage of the number of glia in the UAS-GFP control condition (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). One-way ANOVA was used for statistical analysis and error bars represent SEM.

Journal: Scientific Reports

Article Title: Cyclin-dependent kinase 9 is required for the survival of adult Drosophila melanogaster glia

doi: 10.1038/s41598-017-07179-8

Figure Lengend Snippet: cdk9 is necessary for glial survival. ( a–h ) Representative images of 7d old adult brains immunostained with anti-Repo to label glia for Fig. 1i,j. The images are maximum projections of optical sections. The outlined area demarcates the region of the central brain where the number of glia were quantified. ( i ) Number of anti-Repo-expressing glia in the central brain of 7d old adult flies in mir-31a mutants (mir-31a KO/KO) and where UAS-GFP , UAS-CG16947 , UAS-cdk9 RNAi or UAS-p53 RNAi lines were expressed in glia using Repo-Gal4 . Glia were represented as a percentage of the control animals, Repo-Gal4 > UAS-GFP (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). One-way ANOVA was used for statistical analysis and error bars represent SEM. ( j ) Number of anti-Repo-expressing glia in the central brain of 7d old adult flies. UAS-GFP , UAS-CG16947 and UAS-cdk9 RNAi expression was driven by Repo-Gal4 under the control of tubulin Gal80 ts (tubGal80 ts ). Adult-only expression was achieved by rearing the flies at 18 °C then moving the flies to 29 °C to allow Repo-Gal4 activity after eclosion. Data is represented as a percentage of the number of glia in the UAS-GFP control condition (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). One-way ANOVA was used for statistical analysis and error bars represent SEM.

Article Snippet: 2.5 mg of protein was incubated together with 2 μg of rabbit anti-CG16947 (Lifespan Biosciences, LS-B13598 ), or 2 μg of mouse anti-cdk9 (Novus Biologicals, H00001025-M07) overnight on a tube rotator at 4 °C.

Techniques: Expressing, Control, Activity Assay

cdk9 is necessary for adult glial survival. ( a–d ) Representative images of 7d old adult brains immunostained with anti-Repo to label glia for Fig. 2e,f. The images are maximum projections of optical sections. The outlined area demarcates the region of the central brain where the number of glia were quantified. ( e ) Number of anti-Repo-expressing cells in the central brain of 7d old mir-31a mutants (mir-31a KO/KO) when either UAS-GFP or UAS-cdk9 was expressed only in adult glia with Repo-Gal4 under the control of tubGal80 ts . Repo-Gal4 > UAS-GFP represent otherwise wildtype control animals to demonstrate the effectiveness of CDK9 at restoring the wildtype levels of glia in the adult brain. Data is represented as a percentage of the number of glia in the UAS-GFP control condition (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). One-way ANOVA was used. Error bars represent SEM. ( f ) Number of anti-Repo-expressing cells in the central brain of 7d old adults expressing either UAS-GFP or UAS-cdk9 only in glia with Repo-Gal4 under the control of Gal80 ts . Data is represented as a percentage of the number of glia in the UAS-GF P control condition (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). Unpaired Student’s t-test was used. Error bars represent SEM.

Journal: Scientific Reports

Article Title: Cyclin-dependent kinase 9 is required for the survival of adult Drosophila melanogaster glia

doi: 10.1038/s41598-017-07179-8

Figure Lengend Snippet: cdk9 is necessary for adult glial survival. ( a–d ) Representative images of 7d old adult brains immunostained with anti-Repo to label glia for Fig. 2e,f. The images are maximum projections of optical sections. The outlined area demarcates the region of the central brain where the number of glia were quantified. ( e ) Number of anti-Repo-expressing cells in the central brain of 7d old mir-31a mutants (mir-31a KO/KO) when either UAS-GFP or UAS-cdk9 was expressed only in adult glia with Repo-Gal4 under the control of tubGal80 ts . Repo-Gal4 > UAS-GFP represent otherwise wildtype control animals to demonstrate the effectiveness of CDK9 at restoring the wildtype levels of glia in the adult brain. Data is represented as a percentage of the number of glia in the UAS-GFP control condition (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). One-way ANOVA was used. Error bars represent SEM. ( f ) Number of anti-Repo-expressing cells in the central brain of 7d old adults expressing either UAS-GFP or UAS-cdk9 only in glia with Repo-Gal4 under the control of Gal80 ts . Data is represented as a percentage of the number of glia in the UAS-GF P control condition (left axis). Raw number of Repo-expressing glia in the central brain of the genotypes (right axis). Unpaired Student’s t-test was used. Error bars represent SEM.

Article Snippet: 2.5 mg of protein was incubated together with 2 μg of rabbit anti-CG16947 (Lifespan Biosciences, LS-B13598 ), or 2 μg of mouse anti-cdk9 (Novus Biologicals, H00001025-M07) overnight on a tube rotator at 4 °C.

Techniques: Expressing, Control

cdk9 interacts directly with CG16947. ( a ) Alignment of the Drosophila melanogaster (fly) and human protein sequences of cdk9. Highlighted portion denotes region that the commercial anti-cdk9 antibody was generated against human cdk9 protein. ( b ) CG16947 (50 kDa) was detected in the lysates from Repo-Gal4 > UAS-GFP (Repo > UAS-GFP) and Repo-Gal4 > UAS-CG16947 (Repo > UAS-CG16947) used for co-immunoprecipitation in 3d, e, f and Supplemental Fig. . Kinesin (120 kDa) was used as a loading control to ensure that similar levels of protein were loaded from both genotypes. ( c ) cdk9 (49 kDa) was detected in the lysates from Repo-Gal4 > UAS-GFP (Repo > UAS-GFP) and Repo-Gal4 > UAS-CG16947 (Repo > UAS-CG16947) used for co-immunoprecipitation in 3d, e, f and Supplemental Fig . Kinesin (120 kDa) was used as a loading control to ensure that similar levels of protein were loaded from both genotypes. ( d ) Western blot of anti-CG16947 co-immunoprecipitation. Flies were of either Repo-Gal4 > UAS-GFP (Repo > UAS-GFP) or Repo > UAS-CG16947 (Repo > UAS-CG16947) genotype. Blot was probed with anti-cdk9. Lysate refers to the input for the co-immunoprecipitation. A control condition where the beads were incubated with the anti-CG16947 antibody in the absence of lysate was done to distinguish anti-CG16947 antibody elution from the beads versus the CG16947 protein itself. A 49 kDa cdk9 band was detected in the lysates and the without DTT elution of the anti-rchy1 pulldown in both Repo-Gal4 > UAS-GFP (Repo > UAS-GFP) and Repo-Gal4 > UAS-CG16947 (Repo > UAS-CG16947) conditions. ( e ) Co-immunoprecipitation with anti-cdk9. Anti-cdk9 pulled down CG16947 protein (50 kDa). An increase in the number and intensity of the bands recognised by anti-CDK9 in the MG132-treated samples compared to when the lysate and co-immunoprecipitation was done without MG132 suggest that CG16947 was actively degraded via the proteasome in vitro . The multiple bands observed below the expected size for CG16947 likely represent degraded CG16947, which can be observed when the proteasome is inhibited in vitro . ( f ) Co-immunoprecipitation with anti-cdk9. anti-cdk9 pulled down cdk9 protein that was ubiquitinated as shown by the bands above the expected size for cdk9, 49 kDa and degraded, as shown by the bands below 49 kDa. An increase in the number and intensity of the bands recognised by anti-ubiquitin in the MG132-treated samples demonstrated that cdk9 was actively ubiquitinated and degraded via the proteasome in vitro . A higher exposure of the blot is shown in Supplemental Fig. where ubiquitinated cdk9 and its degraded products can be detected in the lysates without MG132.

Journal: Scientific Reports

Article Title: Cyclin-dependent kinase 9 is required for the survival of adult Drosophila melanogaster glia

doi: 10.1038/s41598-017-07179-8

Figure Lengend Snippet: cdk9 interacts directly with CG16947. ( a ) Alignment of the Drosophila melanogaster (fly) and human protein sequences of cdk9. Highlighted portion denotes region that the commercial anti-cdk9 antibody was generated against human cdk9 protein. ( b ) CG16947 (50 kDa) was detected in the lysates from Repo-Gal4 > UAS-GFP (Repo > UAS-GFP) and Repo-Gal4 > UAS-CG16947 (Repo > UAS-CG16947) used for co-immunoprecipitation in 3d, e, f and Supplemental Fig. . Kinesin (120 kDa) was used as a loading control to ensure that similar levels of protein were loaded from both genotypes. ( c ) cdk9 (49 kDa) was detected in the lysates from Repo-Gal4 > UAS-GFP (Repo > UAS-GFP) and Repo-Gal4 > UAS-CG16947 (Repo > UAS-CG16947) used for co-immunoprecipitation in 3d, e, f and Supplemental Fig . Kinesin (120 kDa) was used as a loading control to ensure that similar levels of protein were loaded from both genotypes. ( d ) Western blot of anti-CG16947 co-immunoprecipitation. Flies were of either Repo-Gal4 > UAS-GFP (Repo > UAS-GFP) or Repo > UAS-CG16947 (Repo > UAS-CG16947) genotype. Blot was probed with anti-cdk9. Lysate refers to the input for the co-immunoprecipitation. A control condition where the beads were incubated with the anti-CG16947 antibody in the absence of lysate was done to distinguish anti-CG16947 antibody elution from the beads versus the CG16947 protein itself. A 49 kDa cdk9 band was detected in the lysates and the without DTT elution of the anti-rchy1 pulldown in both Repo-Gal4 > UAS-GFP (Repo > UAS-GFP) and Repo-Gal4 > UAS-CG16947 (Repo > UAS-CG16947) conditions. ( e ) Co-immunoprecipitation with anti-cdk9. Anti-cdk9 pulled down CG16947 protein (50 kDa). An increase in the number and intensity of the bands recognised by anti-CDK9 in the MG132-treated samples compared to when the lysate and co-immunoprecipitation was done without MG132 suggest that CG16947 was actively degraded via the proteasome in vitro . The multiple bands observed below the expected size for CG16947 likely represent degraded CG16947, which can be observed when the proteasome is inhibited in vitro . ( f ) Co-immunoprecipitation with anti-cdk9. anti-cdk9 pulled down cdk9 protein that was ubiquitinated as shown by the bands above the expected size for cdk9, 49 kDa and degraded, as shown by the bands below 49 kDa. An increase in the number and intensity of the bands recognised by anti-ubiquitin in the MG132-treated samples demonstrated that cdk9 was actively ubiquitinated and degraded via the proteasome in vitro . A higher exposure of the blot is shown in Supplemental Fig. where ubiquitinated cdk9 and its degraded products can be detected in the lysates without MG132.

Article Snippet: 2.5 mg of protein was incubated together with 2 μg of rabbit anti-CG16947 (Lifespan Biosciences, LS-B13598 ), or 2 μg of mouse anti-cdk9 (Novus Biologicals, H00001025-M07) overnight on a tube rotator at 4 °C.

Techniques: Generated, Immunoprecipitation, Control, Western Blot, Incubation, In Vitro, Ubiquitin Proteomics

Table depicting number of samples, mean and SEM of all genotypes tested.

Journal: Scientific Reports

Article Title: Cyclin-dependent kinase 9 is required for the survival of adult Drosophila melanogaster glia

doi: 10.1038/s41598-017-07179-8

Figure Lengend Snippet: Table depicting number of samples, mean and SEM of all genotypes tested.

Article Snippet: 2.5 mg of protein was incubated together with 2 μg of rabbit anti-CG16947 (Lifespan Biosciences, LS-B13598 ), or 2 μg of mouse anti-cdk9 (Novus Biologicals, H00001025-M07) overnight on a tube rotator at 4 °C.

Techniques:

3T3-L1 white preadipocytes were infected with a lentiviral vector expressing human HIRA with C-terminal dTAG and HA double tags, followed by lentiviral CRISPR/Cas9- Hira gRNA to delete endogenous Hira . At D4 of adipogenesis, cells were treated with dTAG-13 for 6h. a , Pie charts depicting the genomic distribution of HIRA binding regions at D4. b , Heat maps were aligned around the center of HIRA binding sites on promoters (6,838), primed enhancers (1,998), active enhancers (AEs, 17,862) and other regions (1,751) at D4. c , Average binding profiles of HIRA-HA, H3K27ac, S5P-Pol II, S2P-Pol II, CDK9 and SPT6 around the center of HIRA + promoters and AEs. Normalized read counts are shown. d , Profiles of HIRA-HA, H3K27ac, S5P-Pol II, S2P-Pol II, CDK9 and SPT6 on gene bodies of HIRA + promoter-associated genes. g , ChIP–Seq profiles of HIRA-HA, H3K27ac, S5P-Pol II, S2P-Pol II, CDK9 and SPT6 were displayed on Adipoq , Mlxipl (ChREBP) and Fasn loci.

Journal: bioRxiv

Article Title: Histone chaperone HIRA facilitates transcription elongation to regulate insulin sensitivity and obesity-associated adipose expansion

doi: 10.1101/2025.03.21.644577

Figure Lengend Snippet: 3T3-L1 white preadipocytes were infected with a lentiviral vector expressing human HIRA with C-terminal dTAG and HA double tags, followed by lentiviral CRISPR/Cas9- Hira gRNA to delete endogenous Hira . At D4 of adipogenesis, cells were treated with dTAG-13 for 6h. a , Pie charts depicting the genomic distribution of HIRA binding regions at D4. b , Heat maps were aligned around the center of HIRA binding sites on promoters (6,838), primed enhancers (1,998), active enhancers (AEs, 17,862) and other regions (1,751) at D4. c , Average binding profiles of HIRA-HA, H3K27ac, S5P-Pol II, S2P-Pol II, CDK9 and SPT6 around the center of HIRA + promoters and AEs. Normalized read counts are shown. d , Profiles of HIRA-HA, H3K27ac, S5P-Pol II, S2P-Pol II, CDK9 and SPT6 on gene bodies of HIRA + promoter-associated genes. g , ChIP–Seq profiles of HIRA-HA, H3K27ac, S5P-Pol II, S2P-Pol II, CDK9 and SPT6 were displayed on Adipoq , Mlxipl (ChREBP) and Fasn loci.

Article Snippet: Anti-S5P-Pol II (13523), anti-S2P-Pol II (13499S), anti-CDK9 (2316T) and anti-SPT6 (15616) were from Cell Signaling Technology.

Techniques: Infection, Plasmid Preparation, Expressing, CRISPR, Binding Assay, ChIP-sequencing

Mutant AIREfsx protein does not interact with P-TEFb. ( A ) Mutant AIREfsx protein does not interact with CDK9. GAL, GAL.AIRE and GAL.AIREfsx chimeras were expressed in HeLa cells. Proteins were immunoprecipitated with anti-GAL antibodies (αGAL) and the co-immunoprecipitation with CDK9 was detected with anti-CDK9 antibodies by western blotting (Top panel, IP:WB). The lower three panels contain 5% of input proteins for immunoprecipitations (WB). ( B ) Mutant AIREfsx protein cannot recruit CDK9 to DNA. Sonicated lysates from HeLa cells co-expressing GAL.AIRE or GAL.AIREfsx fusion proteins and G5HIV2SVEDA were immunoprecipitated with anti-CDK9 (αCDK9) antibodies for ChIP. Enrichment of amplicons is presented as fold enrichment over IgG control (CDK9/IgG). Black and striped bars represent values for the WT GAL.AIRE and mutant GAL.AIREfsx chimeras with SEM depicted by error bars. G5HIV2SVEDA and ChIP amplicons are depicted above and below the bar graph, respectively (promoter, Pr; 5′-end of gene, 5′; 3′-end of gene, 3′, polyadenylation signal, pA; untranscribed region, U). G5HIV2SVEDA contains five GAL binding sites (UAS) and the TATA box (T) upstream of the α-globin gene (αgl) with the inserted fragment from the fibronectin 1 gene (FN1).

Journal: Nucleic Acids Research

Article Title: Patient mutation in AIRE disrupts P-TEFb binding and target gene transcription

doi: 10.1093/nar/gkr527

Figure Lengend Snippet: Mutant AIREfsx protein does not interact with P-TEFb. ( A ) Mutant AIREfsx protein does not interact with CDK9. GAL, GAL.AIRE and GAL.AIREfsx chimeras were expressed in HeLa cells. Proteins were immunoprecipitated with anti-GAL antibodies (αGAL) and the co-immunoprecipitation with CDK9 was detected with anti-CDK9 antibodies by western blotting (Top panel, IP:WB). The lower three panels contain 5% of input proteins for immunoprecipitations (WB). ( B ) Mutant AIREfsx protein cannot recruit CDK9 to DNA. Sonicated lysates from HeLa cells co-expressing GAL.AIRE or GAL.AIREfsx fusion proteins and G5HIV2SVEDA were immunoprecipitated with anti-CDK9 (αCDK9) antibodies for ChIP. Enrichment of amplicons is presented as fold enrichment over IgG control (CDK9/IgG). Black and striped bars represent values for the WT GAL.AIRE and mutant GAL.AIREfsx chimeras with SEM depicted by error bars. G5HIV2SVEDA and ChIP amplicons are depicted above and below the bar graph, respectively (promoter, Pr; 5′-end of gene, 5′; 3′-end of gene, 3′, polyadenylation signal, pA; untranscribed region, U). G5HIV2SVEDA contains five GAL binding sites (UAS) and the TATA box (T) upstream of the α-globin gene (αgl) with the inserted fragment from the fibronectin 1 gene (FN1).

Article Snippet: Antibodies used for western blotting, co-immunoprecipitation (co-IP), ChIP or immunofluorescence: anti-AIRE (sc-33188 Santa Cruz Biotechnology), anti-Flag (M2 Sigma-Aldrich), anti-CDK9 (sc-484 Santa Cruz Biotechnology, ab10874 Abcam), anti-RNAPII (ab5408 Abcam, MMS-126 R Covance), anti-S2P (ab5095 Abcam), anti-GAL (sc-510 Santa Cruz Biotechnology), anti-GAPDH (AM4300 Ambion), anti-α Tubulin (DM1A Sigma-Aldrich), anti-U5-116 kD (A300-957A Bethyl labs) rabbit and mouse control IgG (Santa Cruz Biotechnology).

Techniques: Mutagenesis, Immunoprecipitation, Western Blot, Sonication, Expressing, Binding Assay

AIRE requires CDK9 for its effects on pre-mRNA splicing. ( A ) Time course of CDK9 siRNA knockdown. HeLa cells were transfected with CDK9 or control siRNAs (cntrl). Subsequently, cells were harvested at various time-points and protein levels were determined with specific antibodies by western blotting. In the upper and lower panels, levels of CDK9 and GAPDH are presented, respectively. ( B ) Protein effectors are expressed in CDK9-knockdown cells. HeLa cells were co-transfected with CDK9 or control siRNAs. GAL or the WT GAL.AIRE chimera and G5HIV2dsx were co-expressed as indicated. Protein levels of expressed proteins are presented in the upper two panels with those of CDK9 and tubulin in the lowest panels, respectively. ( C ) CDK9 siRNA knock-down inhibits effects of AIRE on splicing. Upper panel contains a schematic representation of the G5HIV2dsx minigene with amplicons used to amplify spliced, unspliced or total dsx transcripts by RT–qPCR. Relative splicing efficiency was determined and is presented for the WT GAL.AIRE chimera (black bars) as fold activation relative to GAL (white bars) for cells transfected with CDK9 or control siRNAs. Error bars represent SEM.

Journal: Nucleic Acids Research

Article Title: Patient mutation in AIRE disrupts P-TEFb binding and target gene transcription

doi: 10.1093/nar/gkr527

Figure Lengend Snippet: AIRE requires CDK9 for its effects on pre-mRNA splicing. ( A ) Time course of CDK9 siRNA knockdown. HeLa cells were transfected with CDK9 or control siRNAs (cntrl). Subsequently, cells were harvested at various time-points and protein levels were determined with specific antibodies by western blotting. In the upper and lower panels, levels of CDK9 and GAPDH are presented, respectively. ( B ) Protein effectors are expressed in CDK9-knockdown cells. HeLa cells were co-transfected with CDK9 or control siRNAs. GAL or the WT GAL.AIRE chimera and G5HIV2dsx were co-expressed as indicated. Protein levels of expressed proteins are presented in the upper two panels with those of CDK9 and tubulin in the lowest panels, respectively. ( C ) CDK9 siRNA knock-down inhibits effects of AIRE on splicing. Upper panel contains a schematic representation of the G5HIV2dsx minigene with amplicons used to amplify spliced, unspliced or total dsx transcripts by RT–qPCR. Relative splicing efficiency was determined and is presented for the WT GAL.AIRE chimera (black bars) as fold activation relative to GAL (white bars) for cells transfected with CDK9 or control siRNAs. Error bars represent SEM.

Article Snippet: Antibodies used for western blotting, co-immunoprecipitation (co-IP), ChIP or immunofluorescence: anti-AIRE (sc-33188 Santa Cruz Biotechnology), anti-Flag (M2 Sigma-Aldrich), anti-CDK9 (sc-484 Santa Cruz Biotechnology, ab10874 Abcam), anti-RNAPII (ab5408 Abcam, MMS-126 R Covance), anti-S2P (ab5095 Abcam), anti-GAL (sc-510 Santa Cruz Biotechnology), anti-GAPDH (AM4300 Ambion), anti-α Tubulin (DM1A Sigma-Aldrich), anti-U5-116 kD (A300-957A Bethyl labs) rabbit and mouse control IgG (Santa Cruz Biotechnology).

Techniques: Transfection, Western Blot, Quantitative RT-PCR, Activation Assay

By recruiting P-TEFb, AIRE induces splicing of an endogenous TRA gene. ( A ) Schematic representation of the KRT14 gene with primer pairs used to amplify spliced and unspliced transcripts by RT–qPCR. ( B ) WT AIRE and mutant AIREfsx proteins are expressed in 293T cells. Expression of proteins was determined with anti-AIRE and anti-α-tubulin antibodies by western blotting (WB). ( C ) Only the WT AIRE protein induces splicing of the KRT14 pre-mRNA. Relative splicing efficiency was determined and is presented for WT AIRE (black bar) and mutant AIREfsx (hashed bar) proteins as fold activation relative to the empty plasmid vector (C, white bar). Error bars represent SEM. ( D ) WT AIRE protein is expressed in 293T cells treated with FP. Expression of proteins was determined with anti-AIRE and anti-α-tubulin antibodies by western blotting (WB). ( E ) FP blocks AIRE-induced enhancement of KRT14 pre-mRNA splicing. Relative splicing efficiency was determined and is presented for the WT AIRE protein (black bars) as fold activation relative to the empty plasmid vector (C, white bars) for treated and untreated cells (FP, DMSO). Error bars represent SEM. ( F ) P-TEFb is enriched on the KRT14 gene in cells expressing the WT AIRE protein. ChIPs were performed with anti-CDK9 (αCDK9) and control IgG antibodies with lysates from 293T cells expressing the empty plasmid vector (C), WT AIRE or mutant AIREfsx proteins. Enrichment of specific KRT14 amplicons is presented as fold enrichment over IgG control (CDK9/IgG). White, black and striped bars represent values for the empty plasmid vector (C), WT AIRE and mutant AIREfsx proteins, respectively, with SEM depicted by error bars. The KRT14 gene and ChIP amplicons are depicted above the bar graph (promoter, Pr; 5′ of coding region, 5′; 3′ of coding region, 3′; polyadenylation signal, pA). ( G ) ChIP with anti-S2P (αS2P) antibodies. Expression levels for AIRE and α-tubulin proteins are presented below the bar graph (WB). Lysates from transfected cells were analyzed with specific antibodies by western blotting.

Journal: Nucleic Acids Research

Article Title: Patient mutation in AIRE disrupts P-TEFb binding and target gene transcription

doi: 10.1093/nar/gkr527

Figure Lengend Snippet: By recruiting P-TEFb, AIRE induces splicing of an endogenous TRA gene. ( A ) Schematic representation of the KRT14 gene with primer pairs used to amplify spliced and unspliced transcripts by RT–qPCR. ( B ) WT AIRE and mutant AIREfsx proteins are expressed in 293T cells. Expression of proteins was determined with anti-AIRE and anti-α-tubulin antibodies by western blotting (WB). ( C ) Only the WT AIRE protein induces splicing of the KRT14 pre-mRNA. Relative splicing efficiency was determined and is presented for WT AIRE (black bar) and mutant AIREfsx (hashed bar) proteins as fold activation relative to the empty plasmid vector (C, white bar). Error bars represent SEM. ( D ) WT AIRE protein is expressed in 293T cells treated with FP. Expression of proteins was determined with anti-AIRE and anti-α-tubulin antibodies by western blotting (WB). ( E ) FP blocks AIRE-induced enhancement of KRT14 pre-mRNA splicing. Relative splicing efficiency was determined and is presented for the WT AIRE protein (black bars) as fold activation relative to the empty plasmid vector (C, white bars) for treated and untreated cells (FP, DMSO). Error bars represent SEM. ( F ) P-TEFb is enriched on the KRT14 gene in cells expressing the WT AIRE protein. ChIPs were performed with anti-CDK9 (αCDK9) and control IgG antibodies with lysates from 293T cells expressing the empty plasmid vector (C), WT AIRE or mutant AIREfsx proteins. Enrichment of specific KRT14 amplicons is presented as fold enrichment over IgG control (CDK9/IgG). White, black and striped bars represent values for the empty plasmid vector (C), WT AIRE and mutant AIREfsx proteins, respectively, with SEM depicted by error bars. The KRT14 gene and ChIP amplicons are depicted above the bar graph (promoter, Pr; 5′ of coding region, 5′; 3′ of coding region, 3′; polyadenylation signal, pA). ( G ) ChIP with anti-S2P (αS2P) antibodies. Expression levels for AIRE and α-tubulin proteins are presented below the bar graph (WB). Lysates from transfected cells were analyzed with specific antibodies by western blotting.

Article Snippet: Antibodies used for western blotting, co-immunoprecipitation (co-IP), ChIP or immunofluorescence: anti-AIRE (sc-33188 Santa Cruz Biotechnology), anti-Flag (M2 Sigma-Aldrich), anti-CDK9 (sc-484 Santa Cruz Biotechnology, ab10874 Abcam), anti-RNAPII (ab5408 Abcam, MMS-126 R Covance), anti-S2P (ab5095 Abcam), anti-GAL (sc-510 Santa Cruz Biotechnology), anti-GAPDH (AM4300 Ambion), anti-α Tubulin (DM1A Sigma-Aldrich), anti-U5-116 kD (A300-957A Bethyl labs) rabbit and mouse control IgG (Santa Cruz Biotechnology).

Techniques: Quantitative RT-PCR, Mutagenesis, Expressing, Western Blot, Activation Assay, Plasmid Preparation, Transfection

Figure 1| Smad3, Smad4, and cyclin-dependent kinase 9 (CDK9) complex formation in the development and progression of unilateral ureteral obstruction (UUO). (a) Western blotting (WB) demonstrated expression levels of CDK9 in the kidneys 6 h, 12 h, 2 days (d), 4d, and 7d after sham or UUO surgery. (b) Quantitation of relative signal intensities of CDK9/α-tubulin. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group; #Po0.05, versus UUO 12-h group; $Po0.05, versus UUO 24-h group. (c–l) Confocal microscopy demonstrated the expression of CDK9 (green, d, h), α-smooth muscle actin (α-SMA, red, e, i), merged (f, j, k–m) and DAPI (4,6-diamidino-2-phenylindole; blue, c, g) in the mouse kidney with sham operation (c–f) and kidney with UUO (g–m). c–j, × 600. (k) Area in (j), × 1800. Arrows: samples of CDK9+/α-SMA+ myofibroblasts cells. (l) Quantitation of the percentages of CDK9+/α-SMA+ cells in total DAPI(+) cells. (m) Immunoprecipitation (IP)/WB demonstrated the interactions between Smad3 and Smad4, and Smad3 and CDK9 in the kidneys 6 h, 12 h, 2d, 4d, and 7d after sham or UUO surgery. (n) Quantitation of relative signal intensities of Smad4/Smad3 and CDK9/Smad3. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group.

Journal: Kidney international

Article Title: The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction.

doi: 10.1038/ki.2015.235

Figure Lengend Snippet: Figure 1| Smad3, Smad4, and cyclin-dependent kinase 9 (CDK9) complex formation in the development and progression of unilateral ureteral obstruction (UUO). (a) Western blotting (WB) demonstrated expression levels of CDK9 in the kidneys 6 h, 12 h, 2 days (d), 4d, and 7d after sham or UUO surgery. (b) Quantitation of relative signal intensities of CDK9/α-tubulin. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group; #Po0.05, versus UUO 12-h group; $Po0.05, versus UUO 24-h group. (c–l) Confocal microscopy demonstrated the expression of CDK9 (green, d, h), α-smooth muscle actin (α-SMA, red, e, i), merged (f, j, k–m) and DAPI (4,6-diamidino-2-phenylindole; blue, c, g) in the mouse kidney with sham operation (c–f) and kidney with UUO (g–m). c–j, × 600. (k) Area in (j), × 1800. Arrows: samples of CDK9+/α-SMA+ myofibroblasts cells. (l) Quantitation of the percentages of CDK9+/α-SMA+ cells in total DAPI(+) cells. (m) Immunoprecipitation (IP)/WB demonstrated the interactions between Smad3 and Smad4, and Smad3 and CDK9 in the kidneys 6 h, 12 h, 2d, 4d, and 7d after sham or UUO surgery. (n) Quantitation of relative signal intensities of Smad4/Smad3 and CDK9/Smad3. Data are mean ± s.d., n = 6. *Po0.05, versus sham or UUO 6-h group.

Article Snippet: After blocking for 30 min at 4 °C in 5% bovine serum albumin in phosphate-buffered saline with 0.1% Tween 20, the membrane was incubated overnight with rabbit anti-Smad3, CDK9, p-Smad3 Thr179 (Biorbyt, Cambridge, UK), or rabbit antiphospho-Smad3 (Ser423/425) (Cell signaling Technology), or Smad4 (Cell Signalling Technology).

Techniques: Western Blot, Expressing, Quantitation Assay, Confocal Microscopy, Immunoprecipitation

Figure 3| Smad3, Smad4, and cyclin-dependent kinase 9 (CDK9) complex formation in unilateral ureteral obstruction (UUO). (a) Immunoprecipitation (IP)/western blotting (WB) demonstrated the interactions between CDK9 and Smad3 and CDK9 and Smad4 in the kidneys 7 days after sham or UUO surgery. Quantitation of relative signal intensities of (b) Smad3/CDK9 and (c) Smad4/CDK9 7 days after sham or UUO surgery. Data are mean ± s.d., n = 6. *Po0.05 versus WT sham or WT UUO. NS, P40.05 versus WT UUO. (d) IP/WB demonstrated interactions between Smad4 and CDK9 in the kidneys 7 days after sham or UUO surgery in Smad3 wild-type (WT) or Smad3 knockout (KO) mice. (e) WB demonstrated the expression levels of α-smooth muscle actin (α-SMA), fibronectin (FN), collagen I (Col. I) and GAPDH (glyceraldehyde 3-phosphate dehydrogenase) in the kidneys 7 days after sham or UUO surgery in Smad3 WT or Smad3 KO mice. (f) Quantitation of relative signal intensities of α-SMA, FN, and Col. I in the kidneys 7 days after sham or UUO surgery in Smad3 WT or Smad3 KO mice. Data are mean ± s.d., n = 6. *Po0.05; **Po0.01. (g) IP/WB demonstrated interaction between Smad3 and CDK9, phosphorylated Smad3 T179 (p-T179), and phosphorylated Smad3 C-terminus (p-Tail) in the kidneys 7 days after sham or UUO surgery in Smad4 WT or Smad4 KO. (h) WB demonstrated the expression levels of α-SMA, FN, Col. I, and GAPDH in the kidneys 7 days after sham or UUO surgery in Smad4 WT or Smad4 KO mice. (i) Quantitation of relative signal intensities of α-SMA, FN, and Col. I in the kidneys 7 days after sham or UUO surgery in Smad4 WT or Smad4 KO mice. Data are mean ± s.d., n = 6. *Po0.05; ***Po0.001.

Journal: Kidney international

Article Title: The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction.

doi: 10.1038/ki.2015.235

Figure Lengend Snippet: Figure 3| Smad3, Smad4, and cyclin-dependent kinase 9 (CDK9) complex formation in unilateral ureteral obstruction (UUO). (a) Immunoprecipitation (IP)/western blotting (WB) demonstrated the interactions between CDK9 and Smad3 and CDK9 and Smad4 in the kidneys 7 days after sham or UUO surgery. Quantitation of relative signal intensities of (b) Smad3/CDK9 and (c) Smad4/CDK9 7 days after sham or UUO surgery. Data are mean ± s.d., n = 6. *Po0.05 versus WT sham or WT UUO. NS, P40.05 versus WT UUO. (d) IP/WB demonstrated interactions between Smad4 and CDK9 in the kidneys 7 days after sham or UUO surgery in Smad3 wild-type (WT) or Smad3 knockout (KO) mice. (e) WB demonstrated the expression levels of α-smooth muscle actin (α-SMA), fibronectin (FN), collagen I (Col. I) and GAPDH (glyceraldehyde 3-phosphate dehydrogenase) in the kidneys 7 days after sham or UUO surgery in Smad3 WT or Smad3 KO mice. (f) Quantitation of relative signal intensities of α-SMA, FN, and Col. I in the kidneys 7 days after sham or UUO surgery in Smad3 WT or Smad3 KO mice. Data are mean ± s.d., n = 6. *Po0.05; **Po0.01. (g) IP/WB demonstrated interaction between Smad3 and CDK9, phosphorylated Smad3 T179 (p-T179), and phosphorylated Smad3 C-terminus (p-Tail) in the kidneys 7 days after sham or UUO surgery in Smad4 WT or Smad4 KO. (h) WB demonstrated the expression levels of α-SMA, FN, Col. I, and GAPDH in the kidneys 7 days after sham or UUO surgery in Smad4 WT or Smad4 KO mice. (i) Quantitation of relative signal intensities of α-SMA, FN, and Col. I in the kidneys 7 days after sham or UUO surgery in Smad4 WT or Smad4 KO mice. Data are mean ± s.d., n = 6. *Po0.05; ***Po0.001.

Article Snippet: After blocking for 30 min at 4 °C in 5% bovine serum albumin in phosphate-buffered saline with 0.1% Tween 20, the membrane was incubated overnight with rabbit anti-Smad3, CDK9, p-Smad3 Thr179 (Biorbyt, Cambridge, UK), or rabbit antiphospho-Smad3 (Ser423/425) (Cell signaling Technology), or Smad4 (Cell Signalling Technology).

Techniques: Immunoprecipitation, Western Blot, Quantitation Assay, Knock-Out, Expressing

Figure 4| Knockdown of cyclin-dependent kinase 9 (CDK9) decreases transforming growth factor-β1 (TGF-β1)-induced Smad3 linker phosphorylation and fibrotic response in renal fibroblasts. (a) Primary cultured mouse renal fibroblasts were transfected with CDK9 siRNA or a scrambled siRNA control. Two days after transfection, renal fibroblasts were stimulated with recombinant TGF-β1 for (a) 2 days or (b) 30 min. (a) Western blotting (WB) shows the expression of CDK9, α-smooth muscle actin (α-SMA), fibronectin, collagen I, and α-tubulin in renal fibroblasts. (b) Immunoprecipitation (IP)/WB or WB shows the interaction between Smad3 and Smad4, Smad3 p-Tail and nuclear p-T179, and the internal control Histone 2A in renal fibroblasts. Quantification of the relative signal intensities of (c) α-SMA/α-tubulin, fibronectin/α-tubulin, collagen I/α-tubulin, (d) Smad4/Smad3, and p-Tail Smad3/Smad3. Data are mean ± s.d., n = 4. *Po0.05;***Po0.001; NS, not significant.

Journal: Kidney international

Article Title: The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction.

doi: 10.1038/ki.2015.235

Figure Lengend Snippet: Figure 4| Knockdown of cyclin-dependent kinase 9 (CDK9) decreases transforming growth factor-β1 (TGF-β1)-induced Smad3 linker phosphorylation and fibrotic response in renal fibroblasts. (a) Primary cultured mouse renal fibroblasts were transfected with CDK9 siRNA or a scrambled siRNA control. Two days after transfection, renal fibroblasts were stimulated with recombinant TGF-β1 for (a) 2 days or (b) 30 min. (a) Western blotting (WB) shows the expression of CDK9, α-smooth muscle actin (α-SMA), fibronectin, collagen I, and α-tubulin in renal fibroblasts. (b) Immunoprecipitation (IP)/WB or WB shows the interaction between Smad3 and Smad4, Smad3 p-Tail and nuclear p-T179, and the internal control Histone 2A in renal fibroblasts. Quantification of the relative signal intensities of (c) α-SMA/α-tubulin, fibronectin/α-tubulin, collagen I/α-tubulin, (d) Smad4/Smad3, and p-Tail Smad3/Smad3. Data are mean ± s.d., n = 4. *Po0.05;***Po0.001; NS, not significant.

Article Snippet: After blocking for 30 min at 4 °C in 5% bovine serum albumin in phosphate-buffered saline with 0.1% Tween 20, the membrane was incubated overnight with rabbit anti-Smad3, CDK9, p-Smad3 Thr179 (Biorbyt, Cambridge, UK), or rabbit antiphospho-Smad3 (Ser423/425) (Cell signaling Technology), or Smad4 (Cell Signalling Technology).

Techniques: Knockdown, Phospho-proteomics, Cell Culture, Transfection, Control, Recombinant, Western Blot, Expressing, Immunoprecipitation

Figure 5| Cyclin-dependent kinase 9 (CDK9) promotes transforming growth factor-β1 (TGF-β1)-induced collagen I promoter activity. Western blotting (WB) demonstrated expression levels of (a) nuclear or (b) cytoplasm (Cyto) phosphorylated Smad3 T179 (p-T179) in the kidneys after sham or unilateral ureteral obstruction (UUO) surgery. (c) Immunoprecipitation (IP)/WB demonstrated interactions between CDK9 and Smad3 and CDK9 and Smad4 and the levels of p-T179 after TGF-β1 stimulation in mouse renal fibroblasts. (d) Collagen I promoter luciferase assay demonstrated the effects of CDK9 on Smad3, Smad4 and Smad3, and Smad4 enhancement on collagen I promoter activity with or without TGF-β1 stimulation in mouse renal fibroblasts. Data are mean ± s.d. Experiments were repeated three times. Data were analyzed by two- way analysis of variance for different vector transfections and with or without TGF-β1 treatment. Control versus TGF-β1, Po0.05; a–f represent different levels of collagen I promoter luciferase activity. (e) Collagen I luciferase activity assay demonstrated the effects of CDK9 on Smad3 WT or Smad3 linker-mutated enhancement on collagen I promoter activity in mouse renal fibroblasts. Data are mean ± s.d. Experiments were repeated three times. *Po0.05; **Po0.01. (f–h) Collagen I lunciferase activity assay demonstrated the effects of double knockout of Smad3 and Smad4 (Smad3/4 / ) on CDK9 enhancement (f), kinase-dead CDK9 (dnCDK9) on Smad4 enhancement (g), and 3 serine at Smad3 C-terminus replaced with arginine (3S/A) on CDK9 enhancement (h) on collagen I promoter activity in mouse renal fibroblasts. Data are mean ± s.d. Experiments were repeated three times. *Po0.05; **Po0.01; ***Po0.001.

Journal: Kidney international

Article Title: The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction.

doi: 10.1038/ki.2015.235

Figure Lengend Snippet: Figure 5| Cyclin-dependent kinase 9 (CDK9) promotes transforming growth factor-β1 (TGF-β1)-induced collagen I promoter activity. Western blotting (WB) demonstrated expression levels of (a) nuclear or (b) cytoplasm (Cyto) phosphorylated Smad3 T179 (p-T179) in the kidneys after sham or unilateral ureteral obstruction (UUO) surgery. (c) Immunoprecipitation (IP)/WB demonstrated interactions between CDK9 and Smad3 and CDK9 and Smad4 and the levels of p-T179 after TGF-β1 stimulation in mouse renal fibroblasts. (d) Collagen I promoter luciferase assay demonstrated the effects of CDK9 on Smad3, Smad4 and Smad3, and Smad4 enhancement on collagen I promoter activity with or without TGF-β1 stimulation in mouse renal fibroblasts. Data are mean ± s.d. Experiments were repeated three times. Data were analyzed by two- way analysis of variance for different vector transfections and with or without TGF-β1 treatment. Control versus TGF-β1, Po0.05; a–f represent different levels of collagen I promoter luciferase activity. (e) Collagen I luciferase activity assay demonstrated the effects of CDK9 on Smad3 WT or Smad3 linker-mutated enhancement on collagen I promoter activity in mouse renal fibroblasts. Data are mean ± s.d. Experiments were repeated three times. *Po0.05; **Po0.01. (f–h) Collagen I lunciferase activity assay demonstrated the effects of double knockout of Smad3 and Smad4 (Smad3/4 / ) on CDK9 enhancement (f), kinase-dead CDK9 (dnCDK9) on Smad4 enhancement (g), and 3 serine at Smad3 C-terminus replaced with arginine (3S/A) on CDK9 enhancement (h) on collagen I promoter activity in mouse renal fibroblasts. Data are mean ± s.d. Experiments were repeated three times. *Po0.05; **Po0.01; ***Po0.001.

Article Snippet: After blocking for 30 min at 4 °C in 5% bovine serum albumin in phosphate-buffered saline with 0.1% Tween 20, the membrane was incubated overnight with rabbit anti-Smad3, CDK9, p-Smad3 Thr179 (Biorbyt, Cambridge, UK), or rabbit antiphospho-Smad3 (Ser423/425) (Cell signaling Technology), or Smad4 (Cell Signalling Technology).

Techniques: Activity Assay, Western Blot, Expressing, Immunoprecipitation, Luciferase, Plasmid Preparation, Transfection, Control, Double Knockout

Figure 6| Cyclin-dependent kinase 9 (CDK9) inhibitor inhibits transforming growth factor-β1 (TGF-β1)-induced fibrotic response in renal fibroblasts. (a) Collagen I promoter luciferase assay demonstrated effects of CDK9 inhibitor (CDK9i) and Smad3 inhibitor (SIS3) on collagen I promoter activity with or without TGF-β1 stimulation in mouse renal fibroblasts. Data are mean ± s.d. Experiments were repeated three times. Data were analyzed by one-way analysis of variance for different treatments. *Po0.05 versus control; #Po0.05 versus TGF-β1; $Po0.05 versus TGF-β1+CDK9i 50 nM. (b) Western blotting (WB) demonstrated the expression levels of α-smooth muscle actin (α-SMA), collagen I (Col. I), and fibronectin (FN), and internal control α-tubulin 3 days after different treatments in mouse renal fibroblasts. (c) WB demonstrated nuclear phosphorylated Smad3 T179 (Smad3 p-T179) and phosphorylated RNAPII Ser5 (RNAPII p-Ser5) for the indicated period of time of treatments in mouse renal fibroblasts.

Journal: Kidney international

Article Title: The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction.

doi: 10.1038/ki.2015.235

Figure Lengend Snippet: Figure 6| Cyclin-dependent kinase 9 (CDK9) inhibitor inhibits transforming growth factor-β1 (TGF-β1)-induced fibrotic response in renal fibroblasts. (a) Collagen I promoter luciferase assay demonstrated effects of CDK9 inhibitor (CDK9i) and Smad3 inhibitor (SIS3) on collagen I promoter activity with or without TGF-β1 stimulation in mouse renal fibroblasts. Data are mean ± s.d. Experiments were repeated three times. Data were analyzed by one-way analysis of variance for different treatments. *Po0.05 versus control; #Po0.05 versus TGF-β1; $Po0.05 versus TGF-β1+CDK9i 50 nM. (b) Western blotting (WB) demonstrated the expression levels of α-smooth muscle actin (α-SMA), collagen I (Col. I), and fibronectin (FN), and internal control α-tubulin 3 days after different treatments in mouse renal fibroblasts. (c) WB demonstrated nuclear phosphorylated Smad3 T179 (Smad3 p-T179) and phosphorylated RNAPII Ser5 (RNAPII p-Ser5) for the indicated period of time of treatments in mouse renal fibroblasts.

Article Snippet: After blocking for 30 min at 4 °C in 5% bovine serum albumin in phosphate-buffered saline with 0.1% Tween 20, the membrane was incubated overnight with rabbit anti-Smad3, CDK9, p-Smad3 Thr179 (Biorbyt, Cambridge, UK), or rabbit antiphospho-Smad3 (Ser423/425) (Cell signaling Technology), or Smad4 (Cell Signalling Technology).

Techniques: Luciferase, Activity Assay, Control, Western Blot, Expressing

Figure 7| Smad3, Smad4, and cyclin-dependent kinase 9 (CDK9) complex formation in 2-day unilateral ureteral obstruction (UUO) after administration of CDKi or/and SiS3. (a) Western blotting (WB) demonstrated the expression levels of nuclear phosphorylated Smad3 T-179 (p-T179) and Smad3 C-terminus (p-Tail Smad3) in the kidneys 2d after sham or UUO surgery. (b) Quantitation of relative signal intensities of p-T179/Histone 2A and p-Tail Smad3/Smad3. Data are mean ± s.d., n = 6. *Po0.05, versus sham group; #Po0.05, versus UUO vehicle or UUO CDK9i 1 μg/g/day group. (c) Immunoglobulin (IP)/WB demonstrated the interactions between Smad3 and Smad4, Smad3 and CDK9, and Smad4 and CDK9 in the kidneys 2d after sham or UUO surgery. (d) Quantitation of relative signal intensities of Smad4/Smad3, Smad3/CDK9, and Smad4/CDK9. Data are mean ± s.d., n = 6. *Po0.05, versus sham group; #Po0.05, versus UUO vehicle group; $Po0.05, versus UUO CDK9i 4 μg/g/day group or UUO SIS3 2.5 μg/g/day group.

Journal: Kidney international

Article Title: The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction.

doi: 10.1038/ki.2015.235

Figure Lengend Snippet: Figure 7| Smad3, Smad4, and cyclin-dependent kinase 9 (CDK9) complex formation in 2-day unilateral ureteral obstruction (UUO) after administration of CDKi or/and SiS3. (a) Western blotting (WB) demonstrated the expression levels of nuclear phosphorylated Smad3 T-179 (p-T179) and Smad3 C-terminus (p-Tail Smad3) in the kidneys 2d after sham or UUO surgery. (b) Quantitation of relative signal intensities of p-T179/Histone 2A and p-Tail Smad3/Smad3. Data are mean ± s.d., n = 6. *Po0.05, versus sham group; #Po0.05, versus UUO vehicle or UUO CDK9i 1 μg/g/day group. (c) Immunoglobulin (IP)/WB demonstrated the interactions between Smad3 and Smad4, Smad3 and CDK9, and Smad4 and CDK9 in the kidneys 2d after sham or UUO surgery. (d) Quantitation of relative signal intensities of Smad4/Smad3, Smad3/CDK9, and Smad4/CDK9. Data are mean ± s.d., n = 6. *Po0.05, versus sham group; #Po0.05, versus UUO vehicle group; $Po0.05, versus UUO CDK9i 4 μg/g/day group or UUO SIS3 2.5 μg/g/day group.

Article Snippet: After blocking for 30 min at 4 °C in 5% bovine serum albumin in phosphate-buffered saline with 0.1% Tween 20, the membrane was incubated overnight with rabbit anti-Smad3, CDK9, p-Smad3 Thr179 (Biorbyt, Cambridge, UK), or rabbit antiphospho-Smad3 (Ser423/425) (Cell signaling Technology), or Smad4 (Cell Signalling Technology).

Techniques: Western Blot, Expressing, Quantitation Assay

Figure 8| The effects of cyclin-dependent kinase 9 inhibitor (CDK9i) and SiS3 on renal fibrosis and inflammation in unilateral ureteral obstruction (UUO). (a) Western blotting (WB) demonstrated the expression levels of α-smooth muscle actin (α-SMA), collagen I (Col. I), and fibronectin (FN) and internal control α-tubulin in the kidneys 7d after sham or UUO surgery with different treatments. (b) Quantitation of relative signal intensities of α-SMA/α-tubulin, Col. I/α-tubulin, and FN/α-tubulin. Data are mean ± s.d., n = 6. *Po0.05, versus sham group; #Po0.05, versus UUO vehicle group; $Po0.05, versus UUO CDK9i 4 μg/g/day group or UUO SiS3 2.5 μg/g/day group. (c) Quantitation of the number of F4/80+ macrophages in the kidneys 7d after sham or UUO surgery with different treatments. Data are mean ± s.d., n = 6. *Po0.05, versus sham group; #Po0.05, versus UUO vehicle group; $Po0.05, versus UUO CDK9i 4 μg/g/day group or UUO SiS3 2.5 μg/g/day group.

Journal: Kidney international

Article Title: The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction.

doi: 10.1038/ki.2015.235

Figure Lengend Snippet: Figure 8| The effects of cyclin-dependent kinase 9 inhibitor (CDK9i) and SiS3 on renal fibrosis and inflammation in unilateral ureteral obstruction (UUO). (a) Western blotting (WB) demonstrated the expression levels of α-smooth muscle actin (α-SMA), collagen I (Col. I), and fibronectin (FN) and internal control α-tubulin in the kidneys 7d after sham or UUO surgery with different treatments. (b) Quantitation of relative signal intensities of α-SMA/α-tubulin, Col. I/α-tubulin, and FN/α-tubulin. Data are mean ± s.d., n = 6. *Po0.05, versus sham group; #Po0.05, versus UUO vehicle group; $Po0.05, versus UUO CDK9i 4 μg/g/day group or UUO SiS3 2.5 μg/g/day group. (c) Quantitation of the number of F4/80+ macrophages in the kidneys 7d after sham or UUO surgery with different treatments. Data are mean ± s.d., n = 6. *Po0.05, versus sham group; #Po0.05, versus UUO vehicle group; $Po0.05, versus UUO CDK9i 4 μg/g/day group or UUO SiS3 2.5 μg/g/day group.

Article Snippet: After blocking for 30 min at 4 °C in 5% bovine serum albumin in phosphate-buffered saline with 0.1% Tween 20, the membrane was incubated overnight with rabbit anti-Smad3, CDK9, p-Smad3 Thr179 (Biorbyt, Cambridge, UK), or rabbit antiphospho-Smad3 (Ser423/425) (Cell signaling Technology), or Smad4 (Cell Signalling Technology).

Techniques: Western Blot, Expressing, Control, Quantitation Assay